Markedly reduced levels of soluble β-catenin in Alzheimer's disease brain

Jennings, Robert; Kelliher, Mary; O'Neill, Cora

doi:10.1042/bst028a035c

Skip Nav Destination

Article navigation

Conference Abstract| February 01 2000

Markedly reduced levels of soluble β-catenin in Alzheimer's disease brain

Robert Jennings;

Robert Jennings

1Department of Biochemistry, University College, Lee Maltings Cork, Ireland

Search for other works by this author on:

This Site

PubMed

Google Scholar

Mary Kelliher;

Mary Kelliher

1Department of Biochemistry, University College, Lee Maltings Cork, Ireland

Search for other works by this author on:

This Site

PubMed

Google Scholar

Cora O'Neill

1Department of Biochemistry, University College, Lee Maltings Cork, Ireland

Search for other works by this author on:

This Site

PubMed

Google Scholar

Author and article information

Publisher: Portland Press Ltd

Online ISSN: 1470-8752

Print ISSN: 0300-5127

2000

Biochem Soc Trans (2000) 28 (1): A35.

https://doi.org/10.1042/bst028a035c

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press

Registered address – Office 605, Albert House, 256-260 Old St, London EC1V 9DD

Portland Press Tel
+44 (0)20 3880 2795
Portland Press Company no. 02453983

Biochemical Society Tel
+44 (0)20 3880 2793
Email: [email protected]

Biochemical Society Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Markedly reduced levels of soluble β-catenin in Alzheimer's disease brain

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

Open Access for all

CONNECT

EXPLORE

Cover Image

Markedly reduced levels of soluble β-catenin in Alzheimer's disease brain Available to Purchase

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

Open Access for all

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only

Markedly reduced levels of soluble β-catenin in Alzheimer's disease brain